Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Masini

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|August 17, 2023
Rituximab in steroid-refractory immune-related pancreatitis: a case reportArmando Santoro, Silvia Masini, Raffaele Cavina, et al.
Cancers|May 11, 2024
Retreatment with Immune Checkpoint Inhibitors in the New Scenario of Immunotherapy in Non-Small Cell Lung CancerSabrina Rossi, Silvia Masini, Giovanna Finocchiaro, et al.
Fertility and Sterility|September 9, 2008
Thrombin-activatable fibrinolysis inhibitor polymorphisms and recurrent pregnancy lossSilvia Masini, Carlo Ticconi, Paolo Gravina, et al.
Clinical Chemistry and Laboratory Medicine|June 2, 2011
Impact of storage conditions on genetic analysis or viral load determination in clinical specimensPaolo Gravina, Marco Ciotti, Silvia Masini, et al.
Psychiatry Research|November 25, 2010
Genetic polymorphisms of glutathione S-transferases GSTM1, GSTT1, GSTP1 and GSTA1 as risk factors for schizophreniaPaolo Gravina, Ilaria Spoletini, Silvia Masini, et al.
Biomedicines|February 27, 2026
<i>PIK3CA</i> Alterations in NSCLC: Clinical Characteristics of a "Neglected" Population of Oncogene-Addicted PatientsSabrina Rossi, Arianna Pagliaro, Silvia Masini, et al.
Clinical Transplantation|July 25, 2025
Conditions Associated With the Onset of Cancer After Heart Transplant: Longitudinal Study in 335 RecipientsFabian Patauner, Filomena Boccia, Silvia Masini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2026
Emerging Targeted Therapies for HER2-mutant Non-Small Cell Lung CancerBenedetta Del Rio, Silvia Masini, Camilo Cáceres-Galvis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 15, 2010
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosisSilvia Rossi, Fabio Buttari, Valeria Studer, et al.
Cancers|November 27, 2025
Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study)Silvia Masini, Monica Antoñanzas Basa, Antonio Calles, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|August 17, 2023
Rituximab in steroid-refractory immune-related pancreatitis: a case reportArmando Santoro, Silvia Masini, Raffaele Cavina, et al.
Cancers|May 11, 2024
Retreatment with Immune Checkpoint Inhibitors in the New Scenario of Immunotherapy in Non-Small Cell Lung CancerSabrina Rossi, Silvia Masini, Giovanna Finocchiaro, et al.
Fertility and Sterility|September 9, 2008
Thrombin-activatable fibrinolysis inhibitor polymorphisms and recurrent pregnancy lossSilvia Masini, Carlo Ticconi, Paolo Gravina, et al.
Clinical Chemistry and Laboratory Medicine|June 2, 2011
Impact of storage conditions on genetic analysis or viral load determination in clinical specimensPaolo Gravina, Marco Ciotti, Silvia Masini, et al.
Psychiatry Research|November 25, 2010
Genetic polymorphisms of glutathione S-transferases GSTM1, GSTT1, GSTP1 and GSTA1 as risk factors for schizophreniaPaolo Gravina, Ilaria Spoletini, Silvia Masini, et al.
Biomedicines|February 27, 2026
<i>PIK3CA</i> Alterations in NSCLC: Clinical Characteristics of a "Neglected" Population of Oncogene-Addicted PatientsSabrina Rossi, Arianna Pagliaro, Silvia Masini, et al.
Clinical Transplantation|July 25, 2025
Conditions Associated With the Onset of Cancer After Heart Transplant: Longitudinal Study in 335 RecipientsFabian Patauner, Filomena Boccia, Silvia Masini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2026
Emerging Targeted Therapies for HER2-mutant Non-Small Cell Lung CancerBenedetta Del Rio, Silvia Masini, Camilo Cáceres-Galvis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 15, 2010
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosisSilvia Rossi, Fabio Buttari, Valeria Studer, et al.
Cancers|November 27, 2025
Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study)Silvia Masini, Monica Antoñanzas Basa, Antonio Calles, et al.
Pageof 1